Been following PRAN for over 7 years. Maybe that is causing the hesitation to jump in right now. Such an intriguing company with a lot of good research. I need to stop the hesitation and jump in, but am afraid this thing is gonna drop as it has in the past.
What convinced me to pull the trigger was the fact that the CEO stated that the alzheimer patients that had finished phase II are enrolling in good numbers for the open label extension trial. This told me that they were seeing an improvement and wanted to stay on the drug.